PIA-STUDY: Probucol in Alzheimer’s Study
Recruiting TAS, SA, WA Summary: Scientists have discovered that a build-up of molecules in the blood may cause damage to brain capillaries, potentially contributing to Alzheimer’s disease. The primary objective of this trial is to evaluate the efficacy of Probucol (Lorelco) on cognitive performance in patients with Alzheimer’s disease (AD) over a 104-week treatment period. […]
PIA-STUDY: Probucol in Alzheimer’s Study Read More »







